Treatment of lichen planopilaris with Janus kinase inhibitors

Australasian Journal of DermatologyEarly View RESEARCH LETTER Treatment of lichen planopilaris with Janus kinase inhibitors Gabriela A. Gonzalez Matheus BHSc, MD, Corresponding Author Gabriela A. Gonzalez Matheus BHSc, MD [email protected] orcid.org/0000-0002-8627-9457 Queensland Institute of Dermatology, Brisbane, Queensland, Australia Correspondence Gabriela A. Gonzalez Matheus, Queensland Institute of Dermatology, 10 Browning Street, Brisbane, Qld 4101, Australia. Email: [email protected]Search for more papers by this authorKiarash Khosrotehrani MD, PhD, FACD, Kiarash Khosrotehrani MD, PhD, FACD Queensland Institute of Dermatology, Brisbane, Queensland, AustraliaSearch for more papers by this author Gabriela A. Gonzalez Matheus BHSc, MD, Corresponding Author Gabriela A. Gonzalez Matheus BHSc, MD [email protected] orcid.org/0000-0002-8627-9457 Queensland Institute of Dermatology, Brisbane, Queensland, Australia Correspondence Gabriela A. Gonzalez Matheus, Queensland Institute of Dermatology, 10 Browning Street, Brisbane, Qld 4101, Australia. Email: [email protected]Search for more papers by this authorKiarash Khosrotehrani MD, PhD, FACD, Kiarash Khosrotehrani MD, PhD, FACD Queensland Institute of Dermatology, Brisbane, Queensland, AustraliaSearch for more papers by this author First published: 29 February 2024 https://doi.org/10.1111/ajd.14240Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. CONFLICT OF INTEREST STATEMENT All authors declare that they have no conflicts of interest. REFERENCES 1Yang CC, Khanna T, Sallee B, Christiano AM, Bordone LA. Tofacitinib for the treatment of lichen planopilaris: a case series. Dermatol Ther. 2018; 31(6):e12656. 10.1111/dth.12656 PubMedWeb of Science®Google Scholar 2Motamed-Sanaye A, Khazaee YF, Shokrgozar M, Alishahi M, Ahramiyanpour N, Amani M. JAK inhibitors in lichen planus: a review of pathogenesis and treatments. J Dermatolog Treat. 2022; 33(8): 3098–3103. 10.1080/09546634.2022.2116926 CASPubMedGoogle Scholar 3Svigos K, Yin L, Fried L, Lo Sicco K, Shapiro J. A practical approach to the diagnosis and management of classic lichen planopilaris. Am J Clin Dermatol. 2021; 22(5): 681–692. 10.1007/s40257-021-00630-7 PubMedWeb of Science®Google Scholar 4Babahosseini H, Tavakolpour S, Mahmoudi HR, Balighi K, Teimourpour A, Ghodsi SZ, et al. Lichen planopilaris: retrospective study on the characteristics and treatment of 291 patients. J Dermatolog Treat. 2019; 30(6): 598–604. 10.1080/09546634.2018.1542480 CASPubMedWeb of Science®Google Scholar 5Assouly P, Reygagne P. Lichen planopilaris: update on diagnosis and treatment. Semin Cutan Med Surg. 2009; 28(1): 3–10. 10.1016/j.sder.2008.12.006 CASPubMedWeb of Science®Google Scholar 6Solimani F, Meier K, Ghoreschi K. Emerging topical and systemic JAK inhibitors in dermatology. Front Immunol. 2019; 10: 2847. 10.3389/fimmu.2019.02847 CASPubMedWeb of Science®Google Scholar 7Meephansan J, Thummakriengkrai J, Ponnikorn S, Yingmema W, Deenonpoe R, Suchonwanit P. Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction. Arch Dermatol Res. 2017; 309(9): 729–738. 10.1007/s00403-017-1777-5 CASPubMedWeb of Science®Google Scholar 8Wei D, Chen Y, Shen Y, Xie B, Song X. Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis. Front Immunol. 2023; 14:1152513. 10.3389/fimmu.2023.1152513 CASPubMedWeb of Science®Google Scholar 9Moussa A, Bhoyrul B, Asfour L, Kazmi A, Eisman S, Sinclair RD. Treatment of lichen planopilaris with baricitinib: a retrospective study. J Am Acad Dermatol. 2022; 87(3): 663–666. 10.1016/j.jaad.2022.02.027 CASPubMedGoogle Scholar 10Plante J, Eason C, Snyder A, Elston D. Tofacitinib in the treatment of lichen planopilaris: a retrospective review. J Am Acad Dermatol. 2020; 83(5): 1487–1489. 10.1016/j.jaad.2020.05.104 CASPubMedWeb of Science®Google Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation